Education
About Us
Working with TipRanks
Follow Us
BeiGene Ltd (HK:6160)
:6160
6160 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$75.45 - HK$174.80
Previous CloseN/A
Volume1.62M
Average Volume (3M)5.11M
Market Cap
HK$243.10B
Enterprise ValueHK$138.75B
Total Cash (Recent Filing)$1.96B
Total Debt (Recent Filing)$298.05M
Price to Earnings (P/E)―
Beta0.99
Next Earnings
May 01, 2025EPS Estimate
-0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.68
Shares Outstanding1,285,297,000
10 Day Avg. Volume3,880,922
30 Day Avg. Volume5,114,309
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.26
Price to Cash Flow (P/CF)-9.40
P/FCF Ratio0.00
Enterprise Value/Market Cap0.57
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit43.14
Enterprise Value/Ebitda-349.28
Forecast
1Y Price Target
HK$201.80Price Target Upside21.42% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
BeiGene Ltd News
PremiumCompany Announcements
BeiGene Reports Strong Revenue Growth and Reduced Losses for 2024
PremiumCompany Announcements
BeiGene to Approve and Publish Annual Results in Hong Kong
PremiumCompany Announcements
BeiGene Secures Key HKEX Waivers to Enhance Strategic Operations
PremiumCompany Announcements
BeiGene Completes Employee Share Purchase Plan---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.78%
Mutual Funds
― Other Institutional Investors
92.06% Public Companies and
Individual Investors
6160 FAQ
What was BeiGene Ltd’s price range in the past 12 months?
BeiGene Ltd lowest stock price was HK$75.45 and its highest was HK$174.80 in the past 12 months.
What is BeiGene Ltd’s market cap?
BeiGene Ltd’s market cap is HK$243.10B.
When is BeiGene Ltd’s upcoming earnings report date?
BeiGene Ltd’s upcoming earnings report date is May 01, 2025 which is in 29 days.
How were BeiGene Ltd’s earnings last quarter?
BeiGene Ltd released its earnings results on Mar 27, 2025. The company reported -HK$0.855 earnings per share for the quarter, missing the consensus estimate of -HK$0.606 by -HK$0.249.
Is BeiGene Ltd overvalued?
According to Wall Street analysts BeiGene Ltd’s price is currently Undervalued.
Does BeiGene Ltd pay dividends?
BeiGene Ltd does not currently pay dividends.
What is BeiGene Ltd’s EPS estimate?
BeiGene Ltd’s EPS estimate is -0.29.
How many shares outstanding does BeiGene Ltd have?
BeiGene Ltd has 1,285,297,000 shares outstanding.
What happened to BeiGene Ltd’s price movement after its last earnings report?
BeiGene Ltd reported an EPS of -HK$0.855 in its last earnings report, missing expectations of -HK$0.606. Following the earnings report the stock price went up 5.208%.
Which hedge fund is a major shareholder of BeiGene Ltd?
Currently, no hedge funds are holding shares in HK:6160
---
BeiGene Ltd Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$201.80 (21.42% Upside)
HK$201.80 (21.42% Upside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
74.76%
12-Months-Change
Fundamentals
Return on Equity
-18.81%
Trailing 12-Months
Asset Growth
1.53%
Trailing 12-Months
Company Description
BeiGene Ltd
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
---
6160 Stock 12 Month Forecast
Average Price Target
HK$201.80
▲(21.42% Upside)
Technical Analysis
Ping An Insurance Company of China
―
Sino Biopharmaceutical
―
CSPC Pharmaceutical Group
―
Wuxi Biologics (Cayman)
―
Viva Biotech Holdings
―
Best Analysts Covering 6160
1 Year
1 Year Success Rate
5/8 ratings generated profit
1 Year Average Return
+12.49%
reiterated a buy rating last month
Copying Jialin Zhang's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +12.49% per trade.
---